Camarillo, CA, United States of America

Arthur J Chirino

This inventor holds 20 USPTO granted patents and 3 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Biopharmaceutical Development. Top assignee: Xencor, Inc.. Active years: 2006-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur J Chirino. Retrieved from https://idiyas.com/inventor/arthur-j-chirino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 20 

% Patents Active = 90.0

 

 

Average Co-Inventor Count = 7.8

ph-index = 9

Forward Citations = 898(Granted Patents)


Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fc Variants
Adiponectin Variants
Pharmaceutical Compositions
Tumor Necrosis Factor-Receptor
Treatment Methods
Protein Engineering
Biopharmaceuticals
Optimized Proteins
Therapeutic Applications
Variant Generation
Method of Treatment
20 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Arthur J. Chirino

Introduction

Arthur J. Chirino is a prominent inventor based in Camarillo, California, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 20 patents, he has been instrumental in advancing innovative solutions in antibody technology. His work is particularly focused on optimized Fc variants and methods for their generation, contributing to the development of antibody therapies.

Latest Patents

Among his latest inventions, Arthur has developed techniques related to optimized Fc variants and their generation. This invention encompasses methods for creating antibodies and Fc fusions that incorporate these optimized Fc variants, which may enhance therapeutic efficacy and stability. His consistent efforts in this area highlight his commitment to improving biopharmaceutical technologies.

Career Highlights

Arthur J. Chirino has made remarkable strides in his career at Xencor, Inc., a leading biopharmaceutical company that focuses on developing next-generation antibody therapeutics. His role at Xencor, combined with his extensive patent portfolio, showcases his expertise and leadership in developing innovative solutions that address complex medical challenges.

Collaborations

Throughout his career, Arthur has had the opportunity to collaborate with esteemed colleagues, including John R. Desjarlais and Gregory Alan Lazar. These collaborations have further enriched his research endeavors, fostering a culture of innovation and excellence within the team at Xencor.

Conclusion

In conclusion, Arthur J. Chirino's contributions to the field of antibody technology and his impressive patent portfolio underline the importance of innovation in biopharmaceuticals. His work continues to impact the landscape of therapeutic development, solidifying his reputation as a leading inventor in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…